This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n13http://linked.opendata.cz/resource/drugbank/drug/DB07583/identifier/pdb/
n10http://bio2rdf.org/drugbank:
n14http://linked.opendata.cz/resource/drugbank/drug/DB07583/identifier/pubchem-compound/
admshttp://www.w3.org/ns/adms#
n12http://linked.opendata.cz/resource/drugbank/drug/DB07583/identifier/pubchem-substance/
n9http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n5http://linked.opendata.cz/resource/drugbank/drug/DB07583/identifier/drugbank/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n6http://linked.opendata.cz/ontology/drugbank/
n7http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n4http://linked.opendata.cz/resource/drugbank/drug/DB07583/identifier/chemspider/

Statements

Subject Item
n2:DB07583
rdf:type
n6:Drug
n6:group
experimental
owl:sameAs
n9:DB07583 n10:DB07583
dcterms:title
(4R,2S)-5'-(4-(4-CHLOROBENZYLOXY)PYRROLIDIN-2-YLMETHANESULFONYL)ISOQUINOLINE
adms:identifier
n4:4484361 n5:DB07583 n12:99444054 n13:CQP n14:5327110
n6:IUPAC-Name
n7:271B526E-363D-11E5-9242-09173F13E4C5
n6:InChI
n7:271B5274-363D-11E5-9242-09173F13E4C5
n6:Molecular-Formula
n7:271B5273-363D-11E5-9242-09173F13E4C5
n6:Molecular-Weight
n7:271B5270-363D-11E5-9242-09173F13E4C5
n6:Monoisotopic-Weight
n7:271B5271-363D-11E5-9242-09173F13E4C5
n6:SMILES
n7:271B5272-363D-11E5-9242-09173F13E4C5
n6:Water-Solubility
n7:271B526C-363D-11E5-9242-09173F13E4C5
n6:logP
n7:271B526A-363D-11E5-9242-09173F13E4C5 n7:271B526D-363D-11E5-9242-09173F13E4C5
n6:logS
n7:271B526B-363D-11E5-9242-09173F13E4C5
n6:H-Bond-Acceptor-Count
n7:271B527A-363D-11E5-9242-09173F13E4C5
n6:H-Bond-Donor-Count
n7:271B527B-363D-11E5-9242-09173F13E4C5
n6:InChIKey
n7:271B5275-363D-11E5-9242-09173F13E4C5
n6:Polar-Surface-Area--PSA-
n7:271B5276-363D-11E5-9242-09173F13E4C5
n6:Polarizability
n7:271B5278-363D-11E5-9242-09173F13E4C5
n6:Refractivity
n7:271B5277-363D-11E5-9242-09173F13E4C5
n6:Rotatable-Bond-Count
n7:271B5279-363D-11E5-9242-09173F13E4C5
n6:Bioavailability
n7:271B5280-363D-11E5-9242-09173F13E4C5
n6:Ghose-Filter
n7:271B5282-363D-11E5-9242-09173F13E4C5
n6:MDDR-Like-Rule
n7:271B5283-363D-11E5-9242-09173F13E4C5
n6:Number-of-Rings
n7:271B527F-363D-11E5-9242-09173F13E4C5
n6:Physiological-Charge
n7:271B527E-363D-11E5-9242-09173F13E4C5
n6:Rule-of-Five
n7:271B5281-363D-11E5-9242-09173F13E4C5
n6:Traditional-IUPAC-Name
n7:271B526F-363D-11E5-9242-09173F13E4C5
n6:pKa--strongest-acidic-
n7:271B527C-363D-11E5-9242-09173F13E4C5
n6:pKa--strongest-basic-
n7:271B527D-363D-11E5-9242-09173F13E4C5